IRIS
FERRARI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.247
EU - Europa 1.123
AS - Asia 1.042
Continente sconosciuto - Info sul continente non disponibili 168
SA - Sud America 106
AF - Africa 35
Totale 4.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.176
RU - Federazione Russa 853
SG - Singapore 400
CN - Cina 273
VN - Vietnam 142
IT - Italia 126
BD - Bangladesh 90
BR - Brasile 58
FR - Francia 52
CA - Canada 35
HK - Hong Kong 35
GB - Regno Unito 29
DE - Germania 25
IN - India 25
AR - Argentina 23
MX - Messico 13
IQ - Iraq 12
NL - Olanda 10
ZA - Sudafrica 9
CL - Cile 8
DZ - Algeria 8
CO - Colombia 7
ID - Indonesia 7
ES - Italia 6
JM - Giamaica 5
JO - Giordania 5
PH - Filippine 5
PL - Polonia 5
TR - Turchia 5
JP - Giappone 4
KE - Kenya 4
KR - Corea 4
PK - Pakistan 4
EG - Egitto 3
MA - Marocco 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
SV - El Salvador 3
UA - Ucraina 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BJ - Benin 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
MK - Macedonia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
AT - Austria 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
IE - Irlanda 1
IR - Iran 1
LK - Sri Lanka 1
LT - Lituania 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
VI - Stati Uniti Isole Vergini 1
YE - Yemen 1
Totale 4.554
Salva come PNG Salva come JPEG
Città #
Council Bluffs 495
St Louis 343
San Jose 310
Singapore 224
Ashburn 147
Columbus 138
Chicago 60
New York 56
Lauterbourg 48
Ho Chi Minh City 40
Hanoi 36
Hong Kong 33
Moscow 33
Los Angeles 32
Phoenix 28
Santa Clara 27
Milan 19
Beijing 17
Falkenstein 13
Brooklyn 12
Dallas 12
Las Vegas 12
Orem 12
Buffalo 11
Guangzhou 11
Houston 11
São Paulo 11
Denver 10
Florence 9
Atlanta 8
Philadelphia 8
Rome 8
Chennai 7
Da Nang 7
Jacksonville 7
Montreal 7
Naples 7
Toronto 7
Washington 7
Amsterdam 6
Shanghai 6
Amman 5
Baghdad 5
Boston 5
Cape Town 5
Detroit 5
Erbil 5
Hangzhou 5
Poplar 5
San Francisco 5
The Bronx 5
Yonkers 5
Baltimore 4
Brescia 4
Buenos Aires 4
Charlotte 4
Cleveland 4
Dalian 4
Frankfurt am Main 4
Haiphong 4
Kingston 4
London 4
Milwaukee 4
Murfreesboro 4
Oakland 4
Pisa 4
Qingdao 4
Santiago 4
Shenzhen 4
Tokyo 4
Vercelli 4
Warsaw 4
Berlin 3
Bologna 3
Cairo 3
Clinton Township 3
Damascus 3
Dayton 3
Decatur 3
Grass Valley 3
Kansas City 3
Louisville 3
Mexico City 3
Miami 3
Middletown 3
Montevideo 3
Newark 3
Omaha 3
Reading 3
Richmond 3
Salvador 3
San Antonio 3
San Salvador 3
Springfield 3
Tianjin 3
Tân Tiến 3
Virginia Beach 3
Abidjan 2
Alexandria 2
Allentown 2
Totale 2.511
Salva come PNG Salva come JPEG
Nome #
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies 72
Intracranial Nonstenosing Atherosclerotic Plaques Assessed With Vessel Wall MRI in Patients With Embolic Stroke of Undetermined Source 60
c-Jun N-terminal kinase 3 (JNK3) serum levels in ischemic stroke: preliminary findings for a potential biomarker 58
c-Jun N-terminal kinase 3 serum levels in ischemic stroke: Preliminary findings for a potential biomarker 57
Adapting foundation models for rapid clinical response: intracerebral hemorrhage segmentation in emergency settings 57
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 56
Association between calcification pattern and the presence of intracranial carotid artery vulnerable non-stenosing atherosclerotic plaques in ESUS 54
Bioenergetics of Fluoxetine: a functional proteomic study 53
Predictors of intracranial non-stenosing vulnerable atherosclerotic plaques in ESUS: A risk stratification model 53
Aging and cerebral ischemia during postischemic recovery: enzyme activities of Krebs’ cycle, glutamate and related amino acids as a functional proteomics approach to evaluate the responsiveness of ischemic tissue and drug actions 52
Apomorphine Subcutaneous Infusion Likely Induced Acute Thrombocytopenia in a Patient with Parkinson's Disease and Motor Fluctuations 52
Medial intracranial carotid artery calcifications and hematoma expansion in deep intracerebral hemorrhage 50
A case report of acute thrombocytopenia induced by Apomorphine in a patient with Parkinson's disease with motor fluctuations 49
Marcatori sierici e deficit neurologico: correlazioni nei pazienti con ictus ischemico in fase acuta 49
Association between calcification pattern and the presence of intracranial carotid artery vulnerable non-stenosing atherosclerotic plaques in ESUS 49
Role of JNK3 signaling in acute ischemic stroke cerebroprotection: A systematic review 48
Correlations between acute-phase serum biomarkers and the neurological deficit of ischemic patients at discharge from the Stroke Unit 47
Acute-phase serum biomarkers and ischemic stroke severity 47
Renal function and Neurofilament Light Chain serum concentrations in ischemic stroke 46
Neurofilament light chain serum concentrations and renal functions in acute ischemic stroke patients 46
Case Report: Intensive multidisciplinary motor-cognitive rehabilitation treatment in Gerstmann–Sträussler–Scheinker syndrome 46
Endothelin-1 in embolic stroke of undetermined source patients with complicated non-stenosing intracranial atherosclerotic plaques 45
Cherishing Professional Success and Personal Fulfillment: Resilience as a Pivotal Leadership Competency for Clinical Pharmacologists and Beyond 45
Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients 45
Characterization of a panel of serum biomarkers to define functional outcome in ischemic stroke patients: focus on inflammation 45
Potential role of sequential vessel wall magnetic resonance imaging in monitoring response to antithrombotic therapy in stroke due to intracranial atherosclerotic disease: a case report. 45
Stress hyperglycemia and early neurologic deterioration in diabetic and non-diabetic patients with intracerebral hemorrhage 44
Physiopathology and pharmacology of post-stroke depression: from preclinical evidence to patients’ treatment. 44
Il ruolo della concentrazione sierica dei Neurofilamenti a Catena Leggera (Nf-L) e della Proteina Fibrillare Acida della Glia (GFAP) nella valutazione prognostica del paziente con Ictus Ischemico. 44
Warnings and drawbacks for antipsychotic and mood disorder drug prescriptions in the elderly 44
Acute-phase serum biomarkers and ischemic stroke severity 44
Effect of CDP-Choline on age-dependent modifications of energy and glutamate-linked enzyme activities in synaptic and non-synaptic mitochondria from rat cerebral cortex 43
Fatty-acid Binding Protein-2 (FABP2) serum concentrations and blood lipid profile in ischemic stroke patients 43
Relationships between serum Neurofilament Light Chain and blood inflammatory markers in acute ischemic stroke patients 43
The energy metabolism of cerebral mitochondria obtained from spontaneous hypertensive rats: a proposed experimental model to study the effects of chronic hypertension and of anti-hypertensive drugs 42
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study 42
Antidepressants and cerebral energy metabolism: new functional proteomic insights. 42
Caratterizzazione di un pannello di biomarcatori sierici per definire l’outcome funzionale dei pazienti con ictus ischemico focalizzato sul processo infiammatorio 42
Glutamate metabolism in cerebral mitochondria after ischemia and post-ischemic recovery during aging: relationships with brain energy metabolism 41
Hyperglycemia in acute ischemic stroke: Physiopathological and therapeutic complexity 41
Secondary stroke prevention in intracranial atherosclerosis guided by sequential vessel wall imaging: a case series 41
Emerging therapies for hyperglycemia in acute ischemic stroke: glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors 41
Bioenergetic characterization of lymphocytes from stroke patients 41
Ruolo prognostico degli indici sistemici di infiammazione nell’emorragia intraparenchimale spontanea. 41
Secondary stroke prevention in intracranial atherosclerosis guided by sequential vessel wall imaging: a case series 40
ATP-ases of synaptic plasma membranes in striatum: enzymatic systems for synapses functionality by in vivo administration of L-acetylcarnitine in relation to Parkinson's disease 39
Brain Bioenergetics in Chronic Hypertension: Risk Factor for Acute Ischemic Stroke 39
Bioenergetics of lymphocytes as biomarkers of ischemic stroke patients during aging 39
Relationships between serum Neurofilament Light Chain and blood inflammatory markers in acute ischemic stroke patients 39
Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing 39
Stress hyperglycemia indexes and early neurological deterioration in spontaneous intracerebral hemorrhage 39
Post-stroke depression: mechanisms and pharmacological treatment 39
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study 39
Endothelin-1 in embolic stroke of undetermined source patients with complicated non-stenosing intracranial atherosclerotic plaques 38
The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence 38
Effects of Chronic Hypertension on the Energy Metabolism of Cerebral Cortex Mitochondria in Normotensive and in Spontaneously Hypertensive Rats During Aging 37
Predictors of intracranial non-stenosing vulnerable atherosclerotic plaques in ESUS: A risk stratification model 37
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study. 37
The role of the serum biomarkers NF-L and GFAP in predicting ischemic stroke patients’ outcome. 37
Correlation of Neurofilament Light Chain serum concentrations with renal function in acute ischemic stroke patients 37
Stress hyperglycemia and early neurologic deterioration in diabetic and non-diabetic patients with intracerebral hemorrhage 37
Acute amnestic syndrome in fornix lesions: a systematic review of reported cases with a focus on differential diagnosis 36
Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects 36
Valutazione delle concentrazioni sieriche di Endotelina-1 in pazienti con ictus ischemico acuto sottoposti a procedure di rivascolarizzazione. 36
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study 36
Lymphocytes bioenergetics after stroke: a functional proteomic study 35
Neurofilament light chain serum concentrations and renal functions in acute ischemic stroke patients. 35
Potential role of sequential vessel wall magnetic resonance imaging in monitoring response to antithrombotic therapy in stroke due to intracranial atherosclerotic disease: a case report 35
Prevention of Acute and recurrent stroke by anti-hypertensives: interaction with thrombolysis. 35
Renal function and Neurofilament Light Chain serum concentrations in ischemic stroke 33
Intracranial carotid artery calcification morphology differs in patients with lacunar and nonlacunar acute ischemic strokes 33
Spasmi tonici involontari di un arto da ischemia lacunare pontina: una rara manifestazione clinica d’esordio. 33
Effetto della Somministrazione Acuta di Clonidina sul Metabolismo Energetico Cerebrale. 33
Energy metabolism of cerebral mitochondria during aging, ischemia and post-ischemic recovery assessed by functional proteomics of enzymes 33
I neurofilamenti a catena leggera nella valutazione prognostica del paziente con ictus ischemico acuto. 32
Neuroprotection for ischaemic stroke: current status and challenges 32
Bioenergetics of lymphocytes as potential biomarker in Alzheimer’s Disease: a functional proteomic study 32
Energy Metabolism of Synaptosomes from Different Neuronal Systems of Rat Cerebellum During Aging: A Functional Proteomic Characterization 32
Use of cangrelor in cervical and intracranial stenting for the treatment of acute ischemic stroke: A real life single-center experience 32
Functional proteomics of synaptic plasma membrane ATP-ases of rat hippocampus: Effect of l-acetylcarnitine and relationships with Dementia and Depression pathophysiology 32
Bioenergetic characterization of lymphocytes from stroke patients 32
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 31
I biomarcatori sierici originati dall’unità neurovascolare nel monitoraggio del paziente con ictus ischemico: ruolo dei neurofilamenti a catena leggera. 31
Action of some antidepressants on mitochondrial metabolism of rat cerebral cortex 31
Cerebral ischemia and peripheral energy dysfunction in lymphocytes 31
Functional proteomics as marker for neurological and psychiatric disorders: the first application to dementia for an immediate future 31
Bioenergetic effects of Clonidine on functional proteomics 31
Selective effects of L-acetylcarnitine on energy-utilizing ATPases of synapses derived from hippocampal sub-fields. 31
Prevention of Acute and recurrent stroke by anti-hypertensives: interaction with thrombolysis 30
Lymphocyte bioenergetics in ischemic stroke patients during aging 29
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 29
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine 29
Bioenergetics of Desipramine: a Functional Proteomic Study 28
Prevention of acute and recurrent stroke with statins and interaction with thrombolysis 28
Effect of in vivo L-acetylcarnitine administration on ATP-ases enzyme systems of synaptic plasma membranes from rat cerebral cortex 28
Functional proteomics related to energy metabolism of synaptosomes from different neuronal systems of rat hippocampus during aging 28
Cerebral ischemia and postischemic recovery during aging: metabolomics of Krebs’ cycle , glutamate and related amino acids enzyme activities as a functional approach for responsiveness of ischemic tissue 28
I farmaci incretinici nella terapia dell’iperglicemia nell’ictus ischemico acuto. 28
Functional proteomics of adenosine triphosphatase system in the rat striatum during aging 28
Effects of acetylcholinesterase inhibitors on brain energy metabolism of non-synaptic and synaptic mitochondria. 27
Totale 3.969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 0 1 4 0 0 1
2024/202514 0 0 2 0 0 2 2 1 3 1 1 2
2025/20263.757 0 2 5 3 309 105 815 883 334 761 270 270
2026/2027944 530 414 0 0 0 0 0 0 0 0 0 0
Totale 4.721